{"id":2961,"date":"2018-03-14T00:24:14","date_gmt":"2018-03-14T00:24:14","guid":{"rendered":"http:\/\/www.sarmsthailand.com\/?post_type=product&p=2961"},"modified":"2026-07-24T04:59:40","modified_gmt":"2026-07-24T04:59:40","slug":"rad-140","status":"publish","type":"product","link":"https:\/\/www.sarmsthailand.com\/th\/product\/rad-140\/","title":{"rendered":"RAD-140 (Testolone) 10 mg\/ml (30ml)"},"content":{"rendered":"
\n

Buy RAD-140 Testolone SARM in Thailand<\/h2>\n

RAD-140 Testolone comes in a 30ml liquid bottle containing 10 mg per ml. It is one of the most widely recognized investigational compounds in the SARM category.<\/p>\n

RAD-140 is also known as Testolone and vosilasarm. Testolone is the name most commonly used in the SARM market, while vosilasarm is the formal nonproprietary name associated with the compound.<\/p>\n

\n

RAD-140 Product Specifications<\/h2>\n
\n\n\n\n\n\n\n\n\n
Product<\/th>\nRAD-140 Testolone<\/td>\n<\/tr>\n
Other name<\/th>\nVosilasarm<\/td>\n<\/tr>\n
Concentration<\/th>\n10 mg per ml<\/td>\n<\/tr>\n
Bottle size<\/th>\n30ml<\/td>\n<\/tr>\n
Format<\/th>\nLiquid<\/td>\n<\/tr>\n
Compound class<\/th>\nInvestigational selective androgen receptor modulator<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n

What Is RAD-140?<\/h2>\n

RAD-140 is a nonsteroidal selective androgen receptor modulator developed to interact with androgen receptors in a more tissue-selective way than traditional androgenic compounds.<\/p>\n

The compound attracted research interest because early preclinical work described RAD-140 as potent, orally bioavailable and active in experimental models involving muscle and bone tissue.<\/p>\n

RAD-140 Research and Development<\/h2>\n

The original RAD-140 development program examined the compound as a potential option for conditions involving muscle loss, bone health and other androgen-responsive tissues. Its chemical structure and selective receptor activity helped distinguish it from steroidal androgens during early research.<\/p>\n

RAD-140 later entered human clinical research under the name vosilasarm. A first-in-human phase 1 study evaluated it as an androgen-receptor-targeted agent in patients with advanced breast cancer and reported evidence of target engagement and preliminary antitumor activity in that specific research setting.<\/p>\n

That clinical research was conducted in cancer patients and should not be interpreted as a study of bodybuilding, athletic performance or recreational SARM use.<\/p>\n

Why RAD-140 Is Known as Testolone<\/h2>\n

Testolone is the name commonly used by customers and within the SARM market. RAD-140 is the original development code, while vosilasarm is another recognized name for the same compound. PubChem identifies RAD140, RAD-140, Testolone and vosilasarm as names associated with the same chemical substance.<\/p>\n

Research Status and Limitations<\/h2>\n

RAD-140 remains an investigational compound rather than an approved muscle-building or performance medicine. Published research does not guarantee a particular change in muscle mass, strength, fat levels or athletic performance for an individual.<\/p>\n

RAD-140 and Tested Sport<\/h2>\n

RAD140 is specifically included among the selective androgen receptor modulators prohibited under the World Anti-Doping Agency\u2019s 2026 Prohibited List. Athletes subject to anti-doping testing should avoid exposure to this compound.<\/p>\n

Independent Information Sources<\/h2>\n